Recent research by Han et al. has shown that a dual agonist targeting both GLP-1 and GIP receptors promoted stronger neuroprotection against stroke than the GLP-1 analogue Val(8)-GLP-1(glu-PAL) alone thus suggesting a mechanism mediated by GIPR activation [14]. Here, GIPR is linked to Stroke.